Medical Program: Addressing Gaps in Biomarker Testing for mCRC at Diagnosis

Addressing Gaps in Biomarker Testing for mCRC at Diagnosis

Addressing Gaps in Biomarker Testing for mCRC at Diagnosis
RestartResume

Are we taking full advantage of biomarker testing as a prognostic and predictive tool once a patient is diagnosed with colorectal cancer?

  • Overview

    Since biomarker testing can aid in the creation of individualized treatment plans, Dr. Axel Grothey is here to provide his perspective on the current state of biomarker testing for colorectal cancer and how we can increase biomarker testing practices at the time of diagnosis.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free